NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/11/2025
Back to search
Official data from USPTO
JAMES P. ALLISON INSTITUTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
JAMES P. ALLISON INSTITUTE
ST13
US500000097331598Class
35, 36, 41, 42, 44
Filing
97331598
Registration
8023906
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
11/12/2025
Classification
Registered
Trademark type
Word
Nice classes
35, 36, 41, 42, 44
Filing date
03/25/2022
Registration date
11/11/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/11/2025
Last transaction
11/12/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/14/2023
First use in commerce
11/14/2023
Drawing code
4
Owner type
14
Owner location
Austin, TX
Examiner
GLUECK,CHRISTOPHER N
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
The Board of Regents of the University of Texas System
Representatives
Robin Lightner Maisashvili FIBBE LIGHTNER LLP
Technical classification
Nice Classes
Class 35Class 36Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting collaboration within the scientificresearchpharmaceuticalmedical communities to achieve advances in healthcareincluding to accelerate the development and use of immunotherapy in treatment of disease
Class 36
Charitable fundraising services
Class 41
Educational servicesconducting programsseminars and lectures in the fields of science and medicine relating to immunobiologyimmunotherapywellnesscancer and diseases
Class 42
Medical research services; medical researchdevelopmenttechnical designtestinganalysis services in the field of immunobiologyimmunotherapyantibodiesoncology; consulting services in the fields of immunobiologyimmunotherapyantibodiesoncology researchdevelopmenttestinganalysis and data; medical research and development of antibodiestherapeutic productsvaccinesimmunotherapy treatments and diagnostic products; medical research services in the field of immune repertoire analysis and the genome; scientific research in the fields of immunobiologyimmunotherapyantibodies and oncology; biological research; laboratory research services in the fields of immunobiologyimmunotherapyantibodiesoncologycellular engineering; medical laboratory services; providing information on medical and scientific research in the field of immunobiology and immunotherapy; medical and scientific research for others in the field of stem cell researchcancerimmunobiology and immunotherapy; compiling data for research purposes in the field of medical science and medical consultancy; medical and scientific research liaison servicesconsulting in the field of scientific research pertaining to clinical trials in the fields of health caremedicineimmunobiologyimmunotherapypharmacology and biotechnology; collection and management of medical and scientific data for research purposes in the field of medical and scientific research; pharmaceutical research services; pharmaceutical research services relating to cancer
Class 44
Medical services; Medical services relating to cancer; providing medical information; providing health information in the field of immunobiologyimmunotherapyoncology and diseases; providing a web site featuring medical information; providing a web site featuring health information in the field of immunobiologyimmunotherapyoncology and diseases; providing medical informationconsultancy and advisory services; providing information on cancer treatment; providing medical information to patients and medical professionals in the field of immunotherapy and cancer treatment
Publications
History of USPTO decisions and trademark events.
37 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/11/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/20/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/20/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/02/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/02/2025
IUAF
USE AMENDMENT FILED
05/05/2025
EISU
TEAS STATEMENT OF USE RECEIVED
05/05/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/02/2025
EX2G
SOU EXTENSION 2 GRANTED
04/02/2025
EXT2
SOU EXTENSION 2 FILED
04/01/2025
EEXT
SOU TEAS EXTENSION RECEIVED
04/01/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/30/2024
EX1G
SOU EXTENSION 1 GRANTED
09/30/2024
EXT1
SOU EXTENSION 1 FILED
09/30/2024
EEXT
SOU TEAS EXTENSION RECEIVED
09/30/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/06/2024
PUBO
PUBLISHED FOR OPPOSITION
02/06/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/17/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/04/2023
ALIE
ASSIGNED TO LIE
12/04/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/29/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/03/2023
GNRT
NON-FINAL ACTION E-MAILED
04/03/2023
CNRT
NON-FINAL ACTION WRITTEN
04/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/28/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/28/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/28/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/29/2022
GNRT
NON-FINAL ACTION E-MAILED
08/29/2022
CNRT
NON-FINAL ACTION WRITTEN
08/29/2022
DOCK
ASSIGNED TO EXAMINER
08/25/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/30/2022
NWAP
NEW APPLICATION ENTERED
03/29/2022
Continuous trademark protection
Get notified about every new filing that threatens JAMES P. ALLISON INSTITUTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.